Thursday, 28 January 2021

Actify launches Innovative treatment for PTSD, Mental Health disorders

21 August 2019 | News

Leading Mental Healthcare Centers Partner with TRICARE East to offer Transcranial Magnetic Stimulation (TMS) to Military Veterans in the State of Maryland

Actify, a leader in innovative mental health treatment, is proud to support veteran care with the launch of Transcranial Magnetic Stimulation (TMS) in the State of Maryland. With the addition of TMS to the Baltimore and Potomac office locations, Actify is becoming a care provider within the TRICARE East military insurance network, making mental healthcare treatment more easily accessible for veterans.

TMS is FDA-approved for treatment resistant depression, but may also be delivered off-label for OCD, PTSD, and anxiety; all common mental health issues that veterans face.

"TMS is a well-tolerated, non-invasive treatment for depression that is offered in-office. TMS uses a MRI-strength magnetic coil to deliver a low-energy pulse to a targeted area of the brain, and is delivered consistently for four to six weeks to the patient, and then maintenance treatments are given as needed. Results are typically seen within the first two to three weeks," explained Steve Levine, M.D., internationally recognized interventional psychiatrist and Chief Medical Officer with Actify.

"At Actify, we want to give back to veterans who have done their part for others. Now, it's our turn to do our part for them," said Kathy Kaluhiokalani, Actify's CEO. "We are enthusiastic to offer convenient insurance coverage through TRICARE East in both our Baltimore and Potomac offices. We look forward to educating Veterans about Actify and their mental healthcare treatment options, such as TMS."


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls